Publication | Open Access

Quality of Life and Adherence to Therapy in Patients With Chronic Myeloid Leukemia Treated With Nilotinib as a Second-Line Therapy: A Multicenter Prospective Observational Study

Hematological MalignancyQuality Of LifeMedicineHematologyMyeloid NeoplasiaOutcomes ResearchPharmacotherapySecond-line TherapyOncologyRadiation OncologyTherapy ResistanceHealth Sciences